Sana Biotechnology, Inc. (SANA) Misses Q2 EPS by 19c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.39), $0.19 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Crescent Biopharma (CBIO) Reiterated at Buy by Stifel on CR-003/SKB105 Potential
• ROMA Green Finance signs $15M letter of intent for 5% stake in NXTGrid